Login / Signup

Pruritus Severity and Serum Phosphate in CKD: A Post Hoc Analysis of Difelikefalin Studies.

Steven N FishbaneGeoffrey A BlockPieter EvenepoelJeffrey BuddenIsabelle MorinFrédérique MenzaghiWarren WenEdgar V Lerma
Published in: Kidney360 (2024)
No correlation was observed between pruritus severity and sP, or response to placebo or difelikefalin in patients with CKD-aP undergoing HD. Difelikefalin improved itch versus placebo irrespective of baseline sP.
Keyphrases
  • chronic kidney disease
  • atopic dermatitis
  • double blind
  • phase iii
  • transcription factor
  • clinical trial
  • case control
  • randomized controlled trial
  • open label
  • study protocol